Table 1.

Characteristics and questionnaire scores at baseline (before randomisation in original trial) between responders and women not followed-up at 10 yearsa

CharacteristicAll women followed-up at 10 years (n = 206)All women not followed-up (n = 365)
Age at start, years
Mean (SD)41.9 (4.9)41.1 (5.4)
Age ≥35 years, n (%)188 (91.2)324 (88.7)
Ethnicity, n (%)
White178 (86.4)293 (80.2)
Asian11 (5.3)40 (10.9)
Black9 (4.4)21 (5.7)
Other8 (3.8)11 (3.0)
BMI, kg/m2
Mean (SD)29.4 (6.4)29.1 (6.4)
BMI ≥25, n (%)146 (70.8)255 (69.9)
Blood pressure
Systolic blood pressure, mean (SD)129.7 (17.0)128.5 (16.3)
Diastolic blood pressure, mean (SD)78.8 (10.2)78.7 (10.5)
Presentation to primary care for HMB, n (%)
Initial157 (76.2)279 (76.4)
Subsequent49 (23.8)86 (23.6)
Duration of HMB >1 year164 (79.6)296 (81.1)
Menstrual pain151 (73.3)273 (74.8)
Contraception requirement35 (16.9)75 (20.5)
Copper or non-hormonal coil7 (3.4)12 (3.3)
Treatment at randomisation, n (%)
LNG-IUS110 (53.4)175 (47.9)
Usual medical treatments96 (46.6)190 (52.1)
Questionnaire scores, mean (SD) n
SF-36
  Physical functioning82.5 (19.4) 20576.2 (24.6) 339
  Physical role71.7 (24.3) 20569.6 (26.2) 340
  Emotional role72.0 (24.9) 20470.2 (26.6) 339
  Social functioning65.7 (23.7) 20561.9 (26.0) 342
  Mental health60.7 (19.6) 20559.1 (19.5) 340
  Energy and vitality40.8 (21.9) 20540.7 (20.9) 340
  Pain48.5 (22.6) 20545.6 (22.3) 342
  Perception of general health62.2 (21.8) 20560.2 (21.7) 342
EuroQoL EQ-5D
  Descriptive system0.769 (0.228) 2060.714 (0.276) 340
  EQ-5D visual analogue scale71.6 (18.9) 18569.0 (19.7) 311
Sexual Activity Questionnaire
  Pleasure10.5 (5.0) 16611.1 (4.9) 248
  Discomfort4.8 (1.4) 1664.5 (1.7) 248
Menorrhagia Multi-Attribute Score42.8 (19.4) 20639.7 (21.8) 206
  • a If information was partially missing but over half of questions in a domain were answered; the average score of the responses was used, otherwise they were classed as missing. The mean scores and number of contributing participants are slightly different from the original ECLIPSE trial because of this method. BMI = body mass index. HMB = heavy menstrual bleeding. LNG-IUS = levonorgestrel-releasing intrauterine system. SD = standard deviation. SF-36 = 36-item Short-Form Health Survey.